Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernice Benoit

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Archives of Dermatology|August 18, 2010
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppressionSara Samimi, Bernice Benoit, Katherine Evans, et al.
Archives of Dermatology|March 23, 2005
Biological effects of bexarotene in cutaneous T-cell lymphomaJeanne B Budgin, Stephen K Richardson, Sarah B Newton, et al.
The Journal of Molecular Diagnostics : JMD|October 24, 2003
Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practiceManuel Salto-Tellez, Suresh G Shelat, Bernice Benoit, et al.
Leukemia & Lymphoma|September 28, 2011
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphomaMaria Wysocka, Noor Dawany, Bernice Benoit, et al.
American Journal of Hematology|February 28, 2012
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patientsMichael J Kelly-Sell, Youn H Kim, Suzanne Straus, et al.
Blood|June 19, 2008
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptorJulie H Lin, Ellen J Kim, Anand Bansal, et al.
Blood|August 1, 2015
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphomaAlain H Rook, Joel M Gelfand, Joel C Gelfand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2025
Clinicopathological characterization of vacuolar tauopathy associated with VCP D395GRyohei Watanabe, John D Papatriantafyllou, Kengo Maeda, et al.
JAMA Dermatology|October 28, 2020
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular AnalysisJoseph S Durgin, Neha N Jariwala, Maria Wysocka, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Archives of Dermatology|August 18, 2010
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppressionSara Samimi, Bernice Benoit, Katherine Evans, et al.
Archives of Dermatology|March 23, 2005
Biological effects of bexarotene in cutaneous T-cell lymphomaJeanne B Budgin, Stephen K Richardson, Sarah B Newton, et al.
The Journal of Molecular Diagnostics : JMD|October 24, 2003
Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practiceManuel Salto-Tellez, Suresh G Shelat, Bernice Benoit, et al.
Leukemia & Lymphoma|September 28, 2011
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphomaMaria Wysocka, Noor Dawany, Bernice Benoit, et al.
American Journal of Hematology|February 28, 2012
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patientsMichael J Kelly-Sell, Youn H Kim, Suzanne Straus, et al.
Blood|June 19, 2008
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptorJulie H Lin, Ellen J Kim, Anand Bansal, et al.
Blood|August 1, 2015
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphomaAlain H Rook, Joel M Gelfand, Joel C Gelfand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2025
Clinicopathological characterization of vacuolar tauopathy associated with VCP D395GRyohei Watanabe, John D Papatriantafyllou, Kengo Maeda, et al.
JAMA Dermatology|October 28, 2020
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular AnalysisJoseph S Durgin, Neha N Jariwala, Maria Wysocka, et al.
Pageof 1